ACE Report Cover
Intranasal Tapentadol vs Intravenous Paracetamol for pain in Lower Limb Orthopaedic Surgeries
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Language
Download Download Download
Download
Cite this Report Cite this Report Cite this Report
Cite
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Favorites
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Language
Download Download Download
Download
Cite this Report Cite this Report Cite this Report
Cite
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Favorites

PERI-OPERATIVE

Intranasal Tapentadol Versus Intravenous Paracetamol for Postoperative Analgesia in Lower Limb Orthopaedic Surgeries Under Spinal Anaesthesia: A Single Blind RCT.

OrthoEvidence Journal (OE Journal) - ACE Report

OE Journal. 2024;12(22):22 Clin J Pain . 2024 Aug 1;40(8):463-468.

Contributing Authors

P Suresh RV Ningegowda A Ramu

Study Summary

Seventy-four patients undergoing lower limb orthopedic surgeries under spinal anesthesia were randomized to receive either intranasal tapentadol (44.5 mg, n=37) or intravenous paracetamol (1 g, n=37) every 6 hours for 72 hours, starting 3 hours after surgery. The primary outcome was pain intensity measured by the Visual Analog Scale (VAS). Secondary outcomes included systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR), and the need for rescue analgesia. Outcomes were assessed at multiple time points up to 72 hours post-intervention. Overall, the study revealed that intranasal tapentadol resulted in significantly lower pain scores compared to intravenous paracetamol. Additionally, patients in the tapentadol group required no rescue analgesia and exhibited favorable hemodynamic parameters.


Why was this study needed now?

Postoperative pain management remains critical in lower limb orthopedic surgeries. Intranasal tapentadol, a novel centrally acting analgesic with dual mechanisms, offers ease of administration and a favorable safety profile compared to intravenous paracetamol, a commonly used analgesic with predictable pharmacokinetics but requiring complex administration. Despite their individual benefits, no direct comparison of these two agents had been made for postoperative pain relief. This study addresses a significant knowledge gap and seeks to determine the superiority of one approach over the other.

What was the principal research question?

In patients undergoing lower limb orthopedic surgeries under spinal anesthesia, does intranasal tapentadol result in better postoperative analgesia compared to intravenous paracetamol over a 72-hour period?

DISCLAIMER

This content found on this page is for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. If you require medical treatment, always seek the advice of your physician or go to your nearest emergency department. The opinions, beliefs, and viewpoints expressed by the individuals on the content found on this page do not reflect the opinions, beliefs, and viewpoints of OrthoEvidence.

You've reached your limit of 4 free articles views this month

Access to OrthoEvidence for as little as $1.99 per week.

Stay connected with latest evidence. Cancel at any time.
  • Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
  • Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
  • Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Upgrade
Close Dialog
Welcome Back!
Forgot Password?
Start your FREE trial today!

Your account will be affiliated with
and includes free access to OrthoEvidence


OR
Forgot Password?

OR
Please check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see an email, please check your spam or junk folder.

For further assistance, contact our support team.

Please login to enable this feature

To access this feature, you must be logged into an active OrthoEvidence account. Please log in or create a FREE trial account.

Translate ACE Report

OrthoEvidence utilizes a third-party translation service to make content accessible in multiple languages. Please note that while every effort is made to ensure accuracy, translations may not always be perfect.

How to cite this ACE Report

OrthoEvidence. Intranasal Tapentadol vs Intravenous Paracetamol for pain in Lower Limb Orthopaedic Surgeries. OE Journal. 2024;12(22):22. Available from: https://myorthoevidence.com/AceReport/Show/

Copy Citation
Please login to enable this feature

To access this feature, you must be logged into an active OrthoEvidence account. Please log in or create a FREE trial account.

Premium Member Feature

To access this feature, you must be logged into a premium OrthoEvidence account.

Share this ACE Report